Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Shares Issued (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Shares Issued for 5 consecutive years, with $210.5 million as the latest value for Q3 2025.

  • Quarterly Shares Issued changed N/A to $210.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $215.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $215.7 million for FY2025, 44.82% up from the prior year.
  • Shares Issued for Q3 2025 was $210.5 million at Soleno Therapeutics, up from $4.9 million in the prior quarter.
  • The five-year high for Shares Issued was $210.5 million in Q3 2025, with the low at $269000.0 in Q1 2025.